Pharmaceutical ads can significantly impact a patient’s confidence and proactivity in taking control of their health and wellness journey. The COVID-19 crisis that we’ve been facing over the past year has brought this issue into sharper focus, as healthcare and self-advocacy when it comes to pursuing treatment has become more vital than ever.

For this reason, DeepIntent created a consumer-focused survey that helped verify this premise. We surveyed 1,229 U.S. adults to understand how informed they feel by direct-to-consumer (DTC) pharmaceutical ads, including where they most commonly see these ads and how they impact their health and wellness journey.

We found a significant gap between patients and providers when it came to feeling informed and empowered to present treatment options. Some specific statistics that support this conclusion are:

  • Nearly 3 out of 4 respondents agree that more lives could be saved if patients were better informed about their pharmaceutical options.
  • 30% of respondents reported not feeling well informed about prescription drug options before talking with a medical professional.
  • While only 35% of survey respondents consider pharmaceutical advertising relevant to them, this finding demonstrates that advertisers have an opportunity to deliver information that’s pertinent to an individual’s health.
  • Other than speaking with a medical professional (53%), respondents say online web searches for a specific drug (46%) or a medical condition (45%) are their top sources for information.
  • 43% of Americans agree to some extent that pharmaceutical ads being beneficial to others makes them more bearable to watch.

These numbers pose the question: How can advertisers support the relationship between patients and their providers?

The data reinforces that advertising has a strong role to play in the public health domain. Patients even revealed they would be more likely to take a treatment recommendation from a doctor if it had been something they previously saw in an ad. So beyond impressions and brand awareness, there is a big opportunity here for advertisers to help educate patients before they take the next step to speak with their healthcare provider. Through this education, they can have a considerable impact on supporting this mutual relationship, which will ultimately improve patient lives.

  • Chris Paquette

    Chris Paquette serves as the Founder and Chief Executive Officer of DeepIntent. Chris draws upon his multifaceted technical, scientific, and entrepreneurial expertise to provide healthcare marketers with cutting-edge marketing technology solutions. He is also a part of the Forbes Technology Council, an invitation-only community for world-class CEOs, CIOs, CTOs, and technology executives.

Ads

You May Also Like

Social Became a Real Channel at ASCO 2016. Are You Ready?

ASCO 2016 just wrapped up. It’s the Super Bowl of medical conferences and sets ...

Life Style

How To Avoid Holiday Season Weight Gain Until the pharma companies you work for—or ...